Table 1.
Baseline demographics for patients receiving continuous infusion ketamine (n = 24).
| Demographics | Value |
|---|---|
| Weight (kg), median (IQR) (n = 12) | 36 (10–69) |
| Height (inches), median (IQR) (n = 9) | 60 (45–65) |
| Ethnicity, n (%) | |
| Non-Hispanic | 21 (87) |
| Hispanic | 2 (8) |
| Unknown | 1 (4) |
| Race, n (%) | |
| White | 13 (54) |
| Black/African-American | 5 (21) |
| Unknown | 6 (25) |
| Primary ICU type, n (%) | |
| Pediatric | 22 (92) |
| Trauma | 2 (8) |
| Admitting diagnosis, n (%) | |
| Respiratory failure | 12 (50%) |
| Seizure | 3 (12.5) |
| Sepsis | 3 (12.5) |
| Post-op elective surgery | 2 (8) |
| Asthma | 2 (8) |
| Trauma | 1 (4) |
| Abdominal perforation | 1 (4) |
| Relevant comorbidities, n (%) | |
| Seizure | 4 (17) |
| Psychiatric illness | 2 (8) |
| Substance abuse | 1 (4) |
| Renal failure | 1 (4) |
| Tachyarrhythmias | 1 (4) |
| None | 17 (71) |
| Mechanical ventilation, n (%) | 22 (92) |
| Chronic mechanical ventilation | 1 (4.5) |
| Ketamine initiated prior to intubation | 1 (4.5) |
| Ketamine discontinued after extubation | 3 (13.6) |
| Clinical characteristics, n (%) | |
| Continuous vasopressors | 6 (25) |
| Continuous neuromuscular blockade | 8 (33) |
| FiO2 >50% | 11 (46) |
| pH <7.15 | 3 (24) |
| GCS, median (IQR) | 7.5 (3–14) |
| Consult service recommending ketamine, n (%) | |
| Yes | 4 (17) |
| Type of consult service, n (%) | |
| Neurology | 3 (75) |
| Pulmonary | 1 (25) |
IQR: interquartile range; ICU: intensive care unit; FiO2: fraction of inspired oxygen; GCS: Glasgow Coma Scale.